Dainippon Sumitomo Pharma to buy US bio-venture
Dainippon Sumitomo Pharma Co said on Wednesday it will buy US bio-venture Boston Biomedical Inc. for $200 million.
It is reported that Sumitomo Heavy Industries will establish an overseas incorporated entity and construct a new plant in Brazil.